Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

34.58
Delayed Data
As of 10:43am ET
 -0.06 / -0.17%
Today’s Change
21.11
Today|||52-Week Range
35.61
+12.20%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close34.64
Today’s open34.16
Day’s range33.38 - 34.69
Volume17,494
Average volume (3 months)232,926
Market cap$1.2B
Dividend yield--
Data as of 10:43am ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+25.57%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+25.14%
P/E ratio101.7
Price/Sales10.05
Price/Book6.95

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.28+0.97%
ACORAcorda Therapeutics ...+1.05+4.13%
LOXOLoxo Oncology Inc+0.31+0.68%
AIMTAimmune Therapeutics...+0.10+0.44%
Data as of 10:57am ET, 03/27/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs